HCM
Hutchinson Capital Management Portfolio holdings
AUM
$548M
1-Year Return
12.58%
This Quarter Return
+3.44%
1 Year Return
+12.58%
3 Year Return
+50.43%
5 Year Return
+107.91%
10 Year Return
+193.52%
AUM
$299M
AUM Growth
–
Cap. Flow
+$299M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
55.75%
Holding
58
New
58
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
General Motors
GM
|
$18.8M |
| 2 |
Microsoft
MSFT
|
$18.3M |
| 3 |
Johnson Controls International
JCI
|
$18.1M |
| 4 |
Wells Fargo
WFC
|
$18M |
| 5 |
CVS Health
CVS
|
$16.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 23.71% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Industrials | 15.16% |
| 4 | Healthcare | 12.36% |
| 5 | Energy | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Boeing
BA
$174B
| $2.68M | 0.9% |
+26,177
| New | +$2.68M |
|
27
Pfizer
PFE
$140B
| $2.03M | 0.68% |
+76,554
| New | +$2.03M |
|
28
Procter & Gamble
PG
$373B
| $1.59M | 0.53% |
+20,703
| New | +$1.59M |
|
|
COL
29
DELISTED
Rockwell Collins
COL
| $1.59M | 0.53% |
+25,127
| New | +$1.59M |
|
30
PepsiCo
PEP
$201B
| $1.18M | 0.4% |
+14,465
| New | +$1.18M |
|
31
Johnson & Johnson
JNJ
$431B
| $1.13M | 0.38% |
+13,199
| New | +$1.13M |
|
|
CST
32
DELISTED
CST Brands, Inc.
CST
| $1.02M | 0.34% |
+33,092
| New | +$1.02M |
|
33
Clorox
CLX
$15.2B
| $909K | 0.3% |
+10,930
| New | +$909K |
|
34
IBM
IBM
$230B
| $845K | 0.28% |
+4,622
| New | +$845K |
|
35
GE Aerospace
GE
$299B
| $798K | 0.27% |
+7,178
| New | +$798K |
|
36
Target
TGT
$42.1B
| $667K | 0.22% |
+9,689
| New | +$667K |
|
|
RDS.A
37
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $624K | 0.21% |
+9,775
| New | +$624K |
|
38
RTX Corp
RTX
$212B
| $618K | 0.21% |
+10,565
| New | +$618K |
|
39
Genuine Parts
GPC
$19.6B
| $510K | 0.17% |
+6,535
| New | +$510K |
|
40
Bristol-Myers Squibb
BMY
$95B
| $462K | 0.15% |
+10,327
| New | +$462K |
|
41
Schlumberger
SLB
$53.7B
| $443K | 0.15% |
+6,183
| New | +$443K |
|
42
Sempra
SRE
$53.6B
| $432K | 0.14% |
+10,560
| New | +$432K |
|
43
Abbott
ABT
$231B
| $420K | 0.14% |
+12,036
| New | +$420K |
|
44
Coca-Cola
KO
$294B
| $407K | 0.14% |
+10,158
| New | +$407K |
|
45
Marsh & McLennan
MMC
$101B
| $407K | 0.14% |
+10,200
| New | +$407K |
|
46
Novartis
NVS
$249B
| $407K | 0.14% |
+6,427
| New | +$407K |
|
47
3M
MMM
$82.8B
| $390K | 0.13% |
+4,264
| New | +$390K |
|
48
Berkshire Hathaway Class B
BRK.B
$1.09T
| $299K | 0.1% |
+2,668
| New | +$299K |
|
49
Intel
INTC
$108B
| $268K | 0.09% |
+11,072
| New | +$268K |
|
|
MON
50
DELISTED
Monsanto Co
MON
| $249K | 0.08% |
+2,523
| New | +$249K |
|